Company Data
Immix Biopharma Inc.
Ticker
IMMX
Current Price
$2.13 -7.39%
Market Cap
$56.2M
Price Target
Refer to Report
Volume
59.8K
52wk Range
$1.4 - $7.75
Overview
Immix Biopharma Inc is a clinical-stage biopharmaceutical company developing Tissue-Specific Therapeutics in oncology and inflammation. Its product candidate drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME.